Rizo Aleksandra

Rizo Aleksandra is listed in filings as Director at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2026, including 2 public disclosures. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX). The current snapshot covers public activity from Feb 7, 2025 to Feb 6, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.